FDA Drug · D-0470-2025

Levothyroxine Sodium Tablets, USP 112 mcg (0.112mg), 1000 tablets, Rx Only, Manufactured for: Macleods Pharma USA, Inc. Princeton, NJ 08540. Manufactured by: Macleods Pharmaceuticals Ltd. Sarigam, Valsad, Gujarat, India, NDC 33342-398-44.

Class III · Ongoing

Presence of a foreign substance: black hair found embedded in tablet.

Advertisement
Advertisement
Affected lots / codes — check yours against thisLot #: MLF2401A, Exp 01/31/2026
Recalling firm
Macleods Pharmaceuticals Ltd, Mumbai,
Classification
Class III (unlikely to cause harm)
Status
Ongoing
Quantity
1,344- 1000 count bottles
Distribution
Nationwide in the USA
Recall initiated
May 29, 2025
Classified
June 12, 2025
Initiation
Voluntary: Firm initiated
Advertisement
Official source. This record is published by the U.S. FDA through the openFDA enforcement database. View the unmodified government record:
https://api.fda.gov/drug/enforcement.json?search=recall_number%3A%22D-0470-2025%22
Advertisement
Important. Recalls target specific lots and codes — compare the affected lots above against your own product. This page reproduces public FDA data for readability; EveryRecall is independent and not affiliated with the FDA.
Check this brand across all 8 databases →